TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer

Mol Cancer. 2022 Aug 9;21(1):160. doi: 10.1186/s12943-022-01626-5.

Authors

Zequn Li¹, Shougen Cao¹, Yuqi Sun¹, Zhaojian Niu¹, Xiaodong Liu¹, Jun Niu², Yanbing Zhou³

Affiliations

¹ Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
² Department of General Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
³ Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. [email protected].

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Cell Line, Tumor
Humans
Pancreatic Neoplasms* / diagnosis
Pancreatic Neoplasms* / genetics
Prognosis
rac1 GTP-Binding Protein / genetics
rac1 GTP-Binding Protein / metabolism

Substances

Biomarkers
RAC1 protein, human
rac1 GTP-Binding Protein